| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |